NASDAQ:SNWV
SANUWAVE Health, Inc.
SANUWAVE Health, Inc.'s revenue grew 35.0% in fiscal 2025 to $44.1M while operating margin fell to 11.2%. Free cash flow was $1.9M, 4.4% of revenue, and the diluted share count rose 103.5%.Summary generated from SANUWAVE Health, Inc.'s SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$44.1M
Revenue growth+35.0%
Revenue, 5-yr CAGR+61.1%
Gross margin77.1%
Operating margin11.2%
Net margin26.8%
ROICn/a
Return on equityn/a
Debt / equity13.52
Free cash flow$1.9M
FCF margin4.4%
Share count change+103.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 | 17 | 20 | 33 | 44 |
| Operating income | −14 | −9 | −1 | 4 | 5 |
| Net income | −27 | −10 | −26 | −33 | 12 |
| Free cash flow | −7 | n/a | −5 | 2 | 2 |
Recent filings
- 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 8-KNotice of delisting or listing-rule failure
Sep 25, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Jul 13, 2026 - 8-KRegulation FD disclosure
Jun 16, 2026 - 8-KResults of a shareholder vote
Jun 15, 2026